Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
about
A distinctive alveolar macrophage activation state induced by cigarette smokingPolyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorptionUnraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor.Modulation of osteoclast differentiation and bone resorption by Rho GTPasesOsteopontin and mucosal protectionAmelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null miceRas dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureusOsteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Modeling hepatic osteodystrophy in Abcb4 deficient miceAGEs induce ectopic endochondral ossification in intervertebral discsOsteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL productionOsteoporosis increases subsequent risk of gallstone: a nationwide population-based cohort study in Taiwan.Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cellsThrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritisOverride of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.Osteopontin: a bridge between bone and the immune system.Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclastsCD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity.Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice.Bone sialoprotein plays a functional role in bone formation and osteoclastogenesisModulation of biological regulatory networks during nephrogenesis.Supraphysiological Levels of Quercetin Glycosides are Required to Alter Mineralization in Saos2 Cells.High serum osteopontin levels are associated with low bone mineral density in postmenopausal women.The role of osteopontin in inflammatory processesCD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts.Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1.Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.Sequential expression of osteoblast phenotypic genes during medullary bone formation and resorption in estrogen-treated male Japanese quails.Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.Osteoimmunology: memorandum for rheumatologists.The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.Mesenchymal stem cells: key players in cancer progression
P2860
Q24642257-35AB45F9-B143-427B-B26D-C74778AC2ED5Q24797422-CDDDA6FC-0AF4-4BE2-AD47-337907BC0519Q24811484-215797D8-F072-480A-B6D4-DEC91DB03E35Q26851553-C45733AB-10EC-4F46-B54E-A17C634AB6E9Q28236080-DC8568E8-70FA-4DF8-89D9-14406EF06BF4Q28593754-87558430-AFD4-49B6-8345-605E80A4C528Q30375214-EA13CCD0-8CEB-49C3-9F1D-48B48CA696A0Q33221328-70C519A3-7058-44F5-AC7A-3FBBA70CA0F4Q33281521-AD197A08-BF00-44EF-BA3D-406B9013CD98Q33766277-7E703B38-9764-4FB0-B71E-F960A3DB9A1DQ33824596-393E45F4-E68B-48C9-8AE4-0A774EAE2672Q33828356-8EAB6333-2F88-4AF8-8164-2FB5EAE65BEAQ34025702-7D347833-6021-485A-A155-E6843F09B44DQ34144752-D3B46784-80F7-4E97-9FA7-C5D52D8F79D6Q34232152-55CE5627-EA2B-4D47-B91A-B2341202A3EAQ34586754-86BC009D-2055-41CA-A13A-4A99457DACC3Q34684910-C35C025F-63ED-4280-9BCB-2440539B1AFAQ34992484-3B2882BA-4363-4312-A705-1857DD20D7ADQ35005687-9A5C4251-E280-420B-A5F4-3A71DFACB59AQ35087950-C4F9C33D-32AD-4DFB-AEF5-045BE8E940F7Q35178858-53E0F792-E02F-4201-9AB2-C9CF11832D0EQ35688200-7665F4B4-2F47-43CA-B3CE-57BFF10149AEQ36162995-DA561355-0859-41DD-A46B-8C80388A3ED8Q36173877-8114672F-5891-4F32-973C-E06A551EFF05Q36245921-CFB38B0B-B0E9-4AC0-9C62-AFD12A4DB06BQ36610276-2AB7092E-3F93-4D25-90B5-942BA90D5ECBQ36640021-5ABBC83D-88B0-447A-A381-9A2DAB233302Q36673586-9C0D8BE4-5236-4D81-ACC7-611F61624BE7Q36937871-36AACFC4-BF2B-4D38-8AA2-1B9EBCA8E314Q37220487-AFF5E9A7-F6F7-4886-9B0E-92E3850333BBQ37424204-C0E9A3C7-7FF1-42A5-BA9D-81B4B716BFCCQ37683029-A7C99F82-0A25-44B7-BEC8-69EB1C9B5DE9Q37720074-7987914C-F3CF-456D-BB51-EB5F7F19D91EQ37729373-A6556094-4754-409A-8AD0-84EFFBB696B1Q37769582-808E7B3D-7EE0-4F4B-AA31-DAD42EC60CECQ38324327-26CD7933-351C-42EA-AD96-FE4792A88F18Q38737016-FBAA5C20-7005-44AD-9478-EA8DC8AC8103Q38960189-15A0ABF5-32DD-46B4-B60B-8785607C442DQ38961342-AF512FA3-2AC9-4997-A80E-BCA533AB5D18Q39113929-D9109FC2-9ED0-448F-8B81-50D7E61D978E
P2860
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Osteopontin deficiency produce ...... duced CD44 surface expression.
@ast
Osteopontin deficiency produce ...... duced CD44 surface expression.
@en
Osteopontin deficiency produce ...... duced CD44 surface expression.
@nl
type
label
Osteopontin deficiency produce ...... duced CD44 surface expression.
@ast
Osteopontin deficiency produce ...... duced CD44 surface expression.
@en
Osteopontin deficiency produce ...... duced CD44 surface expression.
@nl
prefLabel
Osteopontin deficiency produce ...... duced CD44 surface expression.
@ast
Osteopontin deficiency produce ...... duced CD44 surface expression.
@en
Osteopontin deficiency produce ...... duced CD44 surface expression.
@nl
P2093
P2860
P356
P1476
Osteopontin deficiency produce ...... duced CD44 surface expression.
@en
P2093
D T Denhardt
J Strauss-Schoenberger
K A Hruska
M A Chellaiah
S R Rittling
P2860
P304
P356
10.1091/MBC.E02-06-0354
P577
2003-01-01T00:00:00Z